Brigham researcher in flawed stem cell study will step down – Boston Globe
Boston Globe |
Brigham researcher in flawed stem cell study will step down
Boston Globe A Boston researcher who oversaw a discredited study that described a simple method for creating stem cells will step down from his position as chairman of the anesthesiology department at Brigham and Women’s Hospital and take a one-year sabbatical. Harvard researcher steps downThe Australian |
|
Doctors Hospital Awaiting Final Stem Cell Regulations
Bahamas Tribune DOCTORS Hospital Health System (DHHS) said yesterday that it was anxiously awaiting the final regulations to govern stem cell therapy in the Bahamas, telling Tribune Business that once they are in place “we will go from there”. Barry Rassin, president … |
FDA.gov (blog) |
Stem cell therapy: FDA regulatory science aims to facilitate development of …
FDA.gov (blog) One of FDA’s primary missions is to make sure that the products we approve are safe and effective. There is tremendous interest in the development of regenerative medicine, including numerous proposed products that rely on stem cells. Stem cells have … |
FDA.gov (blog) |
Stem cell therapy: FDA regulatory science aims to facilitate development of …
FDA.gov (blog) One of FDA’s primary missions is to make sure that the products we approve are safe and effective. There is tremendous interest in the development of regenerative medicine, including numerous proposed products that rely on stem cells. Stem cells have … |
|
UCSD Looking For Spinal Cord Injury Patients To Test Stem Cell Treatment
KPBS “The goal of this study is to evaluate the safety of transplanting neural stem cells into the spine for what one day could be a treatment for spinal cord injuries,” said Dr. Joseph Ciacci, the study’s principal investigator and a neurosurgeon at UC San … |
Genetic Engineering & Biotechnology News |
Cancer Stem Cells: An Elusive Target
Genetic Engineering & Biotechnology News The fact that clinical trials are progressing forward in several cancer classes suggests that this field is translating forward and moving toward clinical fulfillment of the promise of treating cancer by addressing the “underlying stem cell“. In this … |